Self-efficacy levels of individuals with type 2 Diabetes Mellitus in the use of diabetes drugs: The example of Gümüşhane and Bayburt province

Basit Öğe Kaydı
dc.contributor.authorDemirag, Hatice
dc.contributor.authorCin, Aynur
dc.contributor.authorDastan, Buket
dc.date.accessioned2024-10-04T19:06:45Z
dc.date.available2024-10-04T19:06:45Z
dc.date.issued2023
dc.departmentBayburt Üniversitesien_US
dc.description.abstractThis study was conducted to determine the self-efficacy levels of individuals with Type 2 Diabetes Mellitus in the use of diabetes medication. The population of the descriptive study consisted of individuals with Type 2 Diabetes Mellitus residing in Gümüşhane and Bayburt provinces. The sample size was determined with the G*Power 3.1.6.9 program. A total of 315 individuals were reached in the study using a snowball sampling method. Data were collected by “Google Form” us- ing “Personal Information Form” and “Diabetes Medication Self-Efficacy Scale”. In the analysis of the data, independent groups t-test, one-way ANOVA test and Pearson product moments correlation test were used. The average age of the individuals with Type 2 Diabetes Mellitus participating in the study was 52.29±14.74 years, the duration of diabetes disease was 9.23±6.25 years, and 81% of them were men. The total average score of the participants from the “Diabetes Medication Self-Efficacy Scale\" was determined as 38.70±12.36 points. It was found that the average total score of the” Diabetes Medication Self-Efficacy Scale\" was higher for women than men, singles than married. Again, the total scale score averages were statistically different according to the occupational group (p<0.001). In addition, the average total score of the “Diabetes Drug Use Self-Efficacy Scale” was found to be higher for individuals who received training on diabetes drug use compared to individuals who did not receive it. It was found that the average scores of the participants from the \"Diabetes Medication Self-Efficacy Scale\" and its sub-dimensions were moderate. In order to increase the diabetes drug use self-efficacy levels of participants diagnosed with Type 2 diabetes, training on the use of diabetes drugs can be expanded.en_US
dc.identifier.doi10.5455/medscience.2023.08.161
dc.identifier.endpage1205en_US
dc.identifier.issn2147-0634
dc.identifier.issue4en_US
dc.identifier.startpage1198en_US
dc.identifier.trdizinid1261390en_US
dc.identifier.urihttps://doi.org/10.5455/medscience.2023.08.161
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1261390
dc.identifier.urihttp://hdl.handle.net/20.500.12403/4684
dc.identifier.volume12en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectdiabetes medicationen_US
dc.subjectnurseen_US
dc.subjectself-efficacyen_US
dc.titleSelf-efficacy levels of individuals with type 2 Diabetes Mellitus in the use of diabetes drugs: The example of Gümüşhane and Bayburt provinceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu